Anuh Pharma gains after receiving GMP certificate from Mexican Health Authority

Anuh Pharma rose 2.4% to Rs 311 at 13:41 IST on BSE after the company received GMP certificate from COFEPRIS for Chloramphenicol and Chloramphenicol Palmitate.

The announcement was made during market hours today, 7 December 2015.

Meanwhile, the BSE Sensex was down 125.54 points, or 0.49%, to 25,512.57

On BSE, so far 27,000 shares were traded in the counter, compared with an average volume of 24,428 shares in the past one quarter.

The stock hit a high of Rs 330 and a low of Rs 304 so far during the day. The stock hit a 52-week low of Rs 103.70 on 22 December 2014. The stock hit a record high of Rs 414.75 on 12 August 2015.

The stock had underperformed the market over the past one month till 4 December 2015, sliding 10.96% compared with 3.45% decline in the Sensex. The scrip, however, outperformed the market in past one quarter, gaining 5.01% as against Sensex's 1.73% rise.

The small-cap pharma firm has an equity capital of Rs 12.53 crore. Face value per share is Rs 5.

Anuh Pharma's net profit surged 56.4% to Rs 7.43 crore on 28.2% rise in total income to Rs 90.44 crore in Q2 September 2015 over Q2 September 2014.

Anuh Pharma manufactures active pharmaceutical ingredients (API's). The company is one of the largest producers of macrolides in the country.

Powered by Capital Market - Live News